Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Breast Neoplasms × palbociclib × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

OTHER 96 INDUSTRY 67 NETWORK 5 UNKNOWN 1 OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasm Metastasis 2 Sarcoma 1 Carcinoma, Hepatocellular 1 Breast Neoplasms 1

Interventions

Tamoxifen 9 Docetaxel 8 Trastuzumab 7 Paclitaxel 6 Letrozole 6 Gemcitabine 6 Exercise 6 Indocyanine Green 5 Cyclophosphamide 5 Control Groups 5 Carboplatin 5 pertuzumab 4 exemestane 4 Doxorubicin 4 Capecitabine 4 Anastrozole 4 dalpiciclib 3 Vinorelbine 3 Standard of Care 3 Radiotherapy 3 Radiation 3 Mammography 3 Cisplatin 3 pyrotinib 2 ferumoxides 2 Zoledronic Acid 2 Tablets 2 Surveys and Questionnaires 2 Surgical Procedures, Operative 2 Radiotherapy, Intensity-Modulated 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03423199 2024-03-22

PATHWAY

National Cancer Center, Japan

Phase 3 Active not recruiting

Breast Neoplasms, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡